Surgical outcomes of gastrointestinal stromal tumors (GIST)Background: Despite that current knowledge regarding the pathology and treatment of Gastrointestinal Stromal Tumors (GIST) is widely available; most patients in the developing world and mainly in rural areas of developing countries have limited access to diagnostic technology and modern specifi c therapy such as imatinib. Objective: To review the management and outcomes of GISTs treated at the hospitals of the IV Region of Chile. Patients and Methods: This retrospective, observational and descriptive study was performed with data obtained from the medical records of 3 community hospitals were all surgical practice of the IV Region is performed. During the study period, 24 consecutive patients with GISTs at different localizations of the gastrointestinal tract were treated. Results: Five patients were operated on with the preoperative diagnostic of GIST, in 19 patients the diagnostic of GIST was suspected during the operation and confi rmed by histology and immunohistochemistry. Most patients were operated on emergency grounds. Of 10 patients requiring imatinib therapy, only 2 are currently receiving the medication sponsored by an international foundation. Conclusions: There were no disparities in the standard surgical care of our patients. The main differences with published series from Chile and developed countries are the available technology to perform a preoperative diagnosis and the availability of imatinib for the treatment of metastatic and recurrent disease.
Intestinal duplication: Diagnosis and treatment of an unusual conditionWe report a 2.5 years old male presenting with abdominal pain, nausea and vomiting lasting 30 days. A CAT scan showed an intestinal duplication cyst. The patient was operated and a cystic lesion of 6 cm diameter was fond and excised along with five cm of terminal ileum. Intestinal transit was reconstituted with a terminal anastomosis between ileum and colon.Key words: Intestinal duplication, intestinal cyst, ileal excision. ResumenReportamos el caso clínico de un paciente de 2 años y 6 meses de edad que fue intervenido quirúrgicamente por una duplicación intestinal del ileon terminal. Discutimos la presentación clínica, estudio radiológico, procedimiento quirúrgico y resultados del tratamiento. Revisamos la literatura actual pertinente haciendo énfasis en el diagnóstico y tratamiento de estas malformaciones por el potencial de malignidad que presentan en la vida adulta.Palabras clave: Duplicación intestinal, malformación intestinal congénita, tumores del ileon. CASO CLÍNICO IntroducciónLas duplicaciones intestinales son anomalías congénitas que se presentan con una frecuencia de 0,2% en niños 1 . Estas malformaciones se han descrito a lo largo de todo el tracto digestivo, desde la base de la lengua hasta el recto [1][2][3][4] . La localización más frecuente de las duplicaciones es el ileon (más del 40% de los casos), y con menor frecuencia se encuentran en esófago, colon, yeyuno, estómago, duodeno y recto [1][2][3][4][5][6][7] . Habitualmente se presentan como duplicaciones únicas, pero pueden ser múlti-ples hasta en el 15% de los casos 1 . La clínica de las duplicaciones intestinales es inespecífica, presentándose con náusea, vómito, dolor abdominal recurrente, presencia de masa abdominal, hemorragia digestiva, perforación y obstrucción intestinal 2 . El diagnóstico preoperatorio de las duplicaciones intestinales hasta una época reciente fue relativamente infrecuente. Actualmente,
Hyperbilirubinemia in appendicitis -is a predictive factor of perforation?Background: An elevated total bilirubin level can be a marker for perforated appendicitis. Aim: To assess and compare the predictive value of total bilirubin, C-reactive protein (CRP), white-blood cell count, the lapse of symptoms evolution, and systemic inflammatory response syndrome (SIRS) for the diagnosis of perforated appendicitis. Material and Methods: Prospective study of 134 consecutive patients aged 33 ± 16 years (63 males) operated for acute appendicitis of whom 49 had a perforated appendix. A preoperative blood sample was obtained to measure total bilirubin, C reactive protein and complete blood count. A systemic inflammatory response score was calculated. Results: The lapse of symptoms before operation was higher in patients with perforated appendicitis compared with their counterparts without perforation (105.2 ± 79.3 and 38.6 ± 17.5 hours respectively). C reactive protein values were 176 ± 82.6 and 80 ± 76 mg/l respectively, (p = 0.01). Serum bilirubin values were 0.7 ± 0.3 and 1.0 ± 0.5 mg/dl, respectively (p = 0.05). Sixty five percent of patients with perforated appendicitis had a SIRS score between 3 and 4 points. A C reactive protein over 76.7 mg/l, a lapse of symptoms over 34.5 hours and a SIRS score of three or more had the best performance for the prediction of perforated appendicitis. Conclusions: The diagnosis of perforated appendicitis may be suspected based on CRP, SIRS, and the lapse of symptoms before operation. We do not recommend the use of total bilirubin to predict perforation in appendicitis. ResumenIntroducción: Se ha propuesto a la hiperbilirrubinemia como un marcador específico de apendicitis perforada. El objetivo del presente estudio es el de comparar el rendimiento para la predicción de perforación de la bilirrubina total (BT) y la proteína C reactiva (PCR), leucocitosis, el tiempo de evolución del cuadro clínico y el síndrome de respuesta inflamatoria sistémica (SIRS). Métodos: Se diseñó un estudio prospectivo y observacional, en el que se aplican curvas Receiver Operating Characteristics para comparar Rev.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.